FDA approves Click’s digital therapeutic for episodic migraine - PharmaTimes More than 37 million adults in the US are affected by migraine

#ClickTherapeutics #digitaltherapeutics #softwareenhanceddrugs #episodicmigraine #migraine #CT132 #preventionofepisodicmigraine #migraineprevention #migrainepatients #ReMMiDclincialtrial #migrainedays #ReMMiDCbridgingstudy #calcitoningenerelatedpeptideinhibitors
pharmatimes.com/news/fda-app...